Abstract
Cancer cells with defective DNA decatenation checkpoint can be selectively targeted by the catalytic inhibitors of DNA topoisomerase IIα (topo IIα) enzyme. Upon treatment with catalytic topo IIα inhibitors, cells with defective decatenation checkpoint fail to arrest their cell cycle in G2 phase and enter into M phase with catenated and under-condensed chromosomes resulting into impaired mitosis and eventually cell death. In the present work we analyzed decatenation checkpoint in five different colon cancer cell lines (HCT116, HT-29, Caco2, COLO 205 and SW480) and in one non-cancerous cell line (HEK293T). Four out of the five colon cancer cell lines i.e. HCT116, HT-29, Caco2, and COLO 205 were found to be compromised for the decatenation checkpoint function at different extents, whereas SW480 and HEK293T cell lines were found to be proficient for the checkpoint function. Upon treatment with ICRF193, decatenation checkpoint defective cell lines failed to arrest the cell cycle in G2 phase and entered into M phase without proper chromosomal decatenation, resulting into the formation of tangled mass of catenated and under-condensed chromosomes. Such cells underwent mitotic catastrophe and rapid apoptosis like cell death and showed h...Continue Reading
References
Dec 1, 1994·Nature·C S DownesR T Johnson
Apr 14, 1997·FEBS Letters·M IwaiR Ishida
Jan 10, 1998·Chromosoma·M J HendzelC D Allis
Apr 1, 2000·Lancet·J Y DouillardP Rougier
Sep 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·S MatsuokaS J Elledge
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·P B DemingW K Kaufmann
Oct 18, 2001·Anti-cancer Drugs·P G Johnston, S Kaye
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·James C Wang
Jul 27, 2002·Science·Kim Nasmyth
Jul 31, 2002·The Journal of Biological Chemistry·Paula B DemingWilliam K Kaufmann
Jul 17, 2003·The Journal of Biological Chemistry·Donald C ChangKathy Q Luo
Dec 18, 2003·Journal of the National Cancer Institute·Sharon C DohertyWilliam K Kaufmann
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John BoyerPatrick G Johnston
Mar 30, 2004·Oncogene·Maria CastedoGuido Kroemer
Apr 13, 2004·Oncogene·Maria CastedoGuido Kroemer
Jul 17, 2004·Cancer Research·Taku NakagawaTakashi Takahashi
Sep 24, 2004·Molecular Cell·Dimitrios A SkoufiasRobert L Margolis
Dec 13, 2005·Cancer Cell·Marc DamelinTimothy H Bestor
Feb 16, 2006·Cell Cycle·Marc Damelin, Timothy H Bestor
Aug 31, 2006·Cell Cycle·Duncan J ClarkeJuan F Giménez-Abián
Sep 16, 2008·Nucleic Acids Research·Elizabeth A WilliamsonRobert Hromas
May 22, 2009·Blood·Justin WrayRobert Hromas
Mar 11, 2010·Current Pharmaceutical Design·José PortugalMarc Bataller
Mar 23, 2010·The Journal of Biological Chemistry·Deborah A Greer CardScott Davey
Apr 8, 2010·Cell Cycle·Jacquelyn J BowerWilliam K Kaufmann
Jun 22, 2010·Oncogene·J J BowerW K Kaufmann
May 3, 2011·Oncogene·G LossaintV Dulić
Jul 12, 2013·The Journal of Investigative Dermatology·Kelly BrooksBrian Gabrielli
Jun 4, 2014·Pigment Cell & Melanoma Research·Kelly BrooksBrian Gabrielli
Citations
Apr 25, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Birgit JanickeKersti Alm
Aug 2, 2018·Cellular and Molecular Life Sciences : CMLS·Andreas Brown, Hartmut Geiger
Nov 13, 2019·The Journal of Cell Biology·Nootan PandeyDuncan J Clarke
Dec 10, 2019·Aging·Cristina Ramos-PérezFélix Machín
Dec 10, 2019·Aging·Ke WangZhi-Nan Chen
Nov 2, 2019·Genes·Joyce H Lee, James M Berger
Jun 27, 2017·NPJ Breast Cancer·Jacquelyn J BowerWilliam K Kaufmann
Apr 12, 2020·Genes·María ArroyoJuan Alberto Marchal
Sep 26, 2020·Toxins·Guillermo Schmeda-HirschmannFélix A Urra
Feb 28, 2020·World Journal of Gastroenterology : WJG·Shi-Tong WangLi-Xuan Sang
Jul 21, 2020·Journal of Chemical Information and Modeling·Mariia RadaevaArtem Cherkasov